# LSL Pharma secures $1.4M in new orders from international clients

LSL Pharma Group announced $1.4 million in new orders from international clients for its Steri-Med subsidiary's sterile ointment products.

- Type: Contract
- Announced: 2024-11-06
- Where: Boucherville, Quebec, Canada
- Value: $1.40M
- Status: completed
- Products: sterile ointment products, Erythromycin 1 gram product
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LSL Pharma Group](https://endata.com/companies/81381.md)
- [Steri-Med Pharma](https://endata.com/companies/81382.md)

## Sources

- [newswire.ca](https://www.newswire.ca/fr/news-releases/lsl-pharma-group-annonces-1-4-million-of-new-orders-from-international-clients-and-completion-of-steri-med-pharma-s-phase-1-production-scale-up-834390081.html), 2024-11-06: "We are excited with the progress made to date at our Steri-Med facility."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
